USPTO serial 79070131
PROJECH SCIENCE TO TECHNOLOGY
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- KAJUBI, ELIZABETH N
- Law office
- TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PROJECH SCIENCE TO TECHNOLOGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Stem cells for medical purposes; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophtalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological bone tissue intended for subsequent implantation, biological skin tissue intended for subsequent implantation, biological kidney tissue intended for subsequent implantation, biological liver tissue intended for subsequent implantation, biological neural tissue intended for subsequent implantation, biological lung tissue intended for subsequent implantation, biological cardiac tissue intended for subsequent implantation, biological dental tissue intended for subsequent implantation, biological muscle tissue intended for subsequent implantation, biological digestive tissue intended for subsequent implantation, biological reproductive tissue intended for subsequent implantation | SECTION 70 - CANCELLED | — |
| 042 | Computer programming in the medical field; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics and phamacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the fields of genomics, cytomics, proteomics and biotechnology; medical and scientific research in the field of genomics, cytomics, proteomics and biotechnology; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 21, 2019 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Dec 20, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 27, 2012 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 17, 2011 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 25, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 25, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 15, 2011 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 23, 2010 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 23, 2010 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 25, 2010 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 25, 2010 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 29, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 27, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 27, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 27, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 26, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 28, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 24, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 23, 2009 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Jul 23, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |